Top Markets
Coin of the day
Albireo Pharma, Inc. Albireo Pharma, Inc.

Albireo Pharma, Inc.

ALBO
Classement en actions #12829
Albireo Pharma, Inc. is a biopharmaceutical company with marketed products,... Albireo Pharma, Inc. is a biopharmaceutical company with marketed products, dedicated to researching, developing, and commercializing new treatments that modify bile acids. The company primarily targets rare liver diseases in children, as well as various other conditions affecting the liver or digestive system. Its portfolio includes Bylvay, a treatment approved for progressive familial intrahepatic cholestasis. Bylvay is also in advanced (Phase III) clinical trials for further pediatric indications such as biliary atresia and Alagille syndrome, which are both uncommon and serious childhood disorders. Additionally, Albireo offers Elobixibat, prescribed for the management of persistent constipation and other functional gastrointestinal issues. Albireo is further advancing its pipeline with A3907, currently undergoing early-stage (Phase I) clinical investigation for adult liver diseases, and A2342, a preclinical candidate designed to address adult viral and liver conditions. The company holds a licensing agreement with EA Pharma Co., Ltd. concerning the development and market rollout of Elobixibat. Albireo Pharma, Inc.'s headquarters are located in Boston, Massachusetts.
Prix de l'action
$44.15
Dernière synchronisation: 2023-03-02
Capitalisation boursière
$545.52M
Changement (1 jour)
-0.23%
Changement (1 an)
0.00%
Pays
US
Échange Albireo Pharma, Inc. (ALBO)

Catégorie

Historique du prix de l'action pour Albireo Pharma, Inc. (ALBO)
Prix de clôture le plus élevé : $44.20 le 2023-03-01

Prix de clôture le plus bas : $22.42 le 2016-11-01
Historique du prix de l'action de Albireo Pharma, Inc. de 2016 à 2026
Performance annuelle du prix de l'action
Année Performance
2023 111.85%
2022 -9.07%
2021 -41.92%
2020 72.73%
2019 -4.50%
2018 -3.43%
2017 12.42%
2016 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.01 -13.08%
AU
$138.18 473.58%
US
$753.02 6.32%
CH